Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.74
+0.27 (4.94%)
At close: Oct 15, 2026, 4:00 PM EDT
5.87
+0.13 (2.26%)
After-hours: Oct 15, 2026, 7:34 PM EDT
Solid Biosciences Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Solid Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $18.71. The average 1-year stock price forecast is 225.96% higher than the current stock price, while the lowest is $11 (+91.64%) and the highest is $26 (+352.96%).
Price Target: $18.71 (+225.96%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Solid Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 8 | 9 | 8 | 9 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 12 | 13 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 15, 2026 |
| UBS | UBS | Buy Initiates $20 | Buy | Initiates | $20 | +248.43% | Oct 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $18 | Buy | Maintains | $18 | +213.59% | Sep 30, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $26 | Buy | Maintains | $26 | +352.96% | Sep 16, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $20 | Buy | Reiterates | $20 | +248.43% | Sep 16, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
8.60M
EPS This Year
-1.76
from -1.99
EPS Next Year
-1.71
from -1.76
EPS and Forward PE are based on non-GAAP adjusted numbers.